Drug Research

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...

The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...

London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...

A New Era of Biopharma Production with AI The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to revolutionise production processes.  Manufacturers are currently facing the most significant challenge in history: the...

The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug discovery is not just a fad but a paradigm shift transforming the way new...

According to a recent analysis released by MarketsandMarkets, the injectable medication delivery market is expected to grow at a compound annual growth rate (CAGR) of about 9% between 2024 and 2029. By 2029, this market is projected to be worth...